S. Imbeaud

发表

Signatures of mutational processes in human cancer

David T. W. Jones, David C. Jones, M. Meyerson, 2013, Nature.

Integrative Annotation of 21,037 Human Genes Validated by Full-Length cDNA Clones

Kanako O. Koyanagi, Michael A. Thomas, H. Mewes, 2004, PLoS Biology.

Loss of hepatocyte nuclear factor 1α function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis

Sandrine Imbeaud, Alain Paris, Laura Pelletier, 2010, Hepatology.

Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.

S. Imbeaud, J. Zucman‐Rossi, Yannick Ladeiro, 2010, Seminars in liver disease.

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2012, Nature Genetics.

Authors’ response: virus–host interactions in HBV-related hepatocellular carcinoma: more to be revealed?

S. Imbeaud, J. Zucman‐Rossi, Q. Cao, 2014, Gut.

Adeno-associated virus in the liver: natural history and consequences in tumour development

Théo Z. Hirsch, S. Imbeaud, J. Zucman‐Rossi, 2019, Gut.

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors

S. Imbeaud, J. Zucman‐Rossi, Cécile Guichard, 2012, Oncoimmunology.

aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2017, PloS one.

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Jessica Zucman-Rossi, Michael R Stratton, Sandrine Imbeaud, 2015, Nature Genetics.

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2018, Nature Communications.

Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas

S. Imbeaud, J. Zucman‐Rossi, V. Paradis, 2020, Gut.

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

Jessica Zucman-Rossi, Sandrine Imbeaud, Julien Calderaro, 2015, Nature Genetics.

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis

Jean-François Deleuze, Jessica Zucman-Rossi, Sandrine Imbeaud, 2017, Nature Communications.

Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.

Charles Auffray, Sandrine Imbeaud, Ji Zhang, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Comparative transcriptomic analysis of salt adaptation in roots of contrasting Medicago truncatula genotypes.

S. Imbeaud, M. Crespi, E. González, 2012, Molecular plant.

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

Sandrine Imbeaud, Sergi Sayols, Manel Esteller, 2015, Hepatology.

Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces

Charles Auffray, Sandrine Imbeaud, Esther Graudens, 2005, Nucleic acids research.

Correction: Integrative Annotation of 21,037 Human Genes Validated by Full-Length cDNA Clones

Kanako O. Koyanagi, Michael A. Thomas, Gopal R. Gopinath, 2004, PLoS biology.

Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

Sabine Tejpar, Bruno Landi, Simona Rossi, 2014, Clinical Cancer Research.

Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas

S. Imbeaud, J. Zucman‐Rossi, J. Calderaro, 2014, Gut.

Hepatocellular Carcinomas With Mutational Activation of Beta Catenin Require Choline and can be Detected by Positron Emission Tomography.

S. Imbeaud, J. Zucman‐Rossi, J. Calderaro, 2019, Gastroenterology.

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry

Cristel G. Thomas, S. Imbeaud, J. Zucman‐Rossi, 2007, Hepatology.

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

S. Imbeaud, J. Zucman‐Rossi, M. Copin, 2020, Molecular oncology.

Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma

Jessica Zucman-Rossi, Sandrine Imbeaud, S. Imbeaud, 2016, Molecular & cellular oncology.

chronic myeloid leukemia apoptosis by imatinib mesylate combined with arsenic trioxide in Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated

C. Auffray, S. Imbeaud, Saijuan Chen, 2008 .

Title Molecular classification of malignant pleural mesothelioma : Identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition

F. Galateau-Sallé, S. Imbeaud, J. Zucman‐Rossi, 2013 .

Mutant Isoforms of the Anti-Müllerian Hormone Type II Receptor Are Not Expressed at the Cell Membrane*

S. Imbeaud, E. Faure, J. Picard, 1996, The Journal of Biological Chemistry.

Unique genomic profile of fibrolamellar hepatocellular carcinoma.

M. Esteller, V. Mazzaferro, S. Imbeaud, 2015, Gastroenterology.

Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant skeletal muscle.

S. Imbeaud, P. Mezin, B. Wuyam, 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

, Marko exercise training in lung transplant skeletal muscle and mitochondrial creatine kinase is enhanced after Functional coupling of adenine nucleotide translocase

S. Imbeaud, P. Mezin, B. Wuyam, 2005 .

Signatures of mutational processes in human cancer this access benefits you. Your matters

David C. Jones, M. Meyerson, R. Eils, 2013 .

Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV.

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Response of human renal tubular cells to cyclosporine and sirolimus: a toxicogenomic study.

P. Beaune, S. Imbeaud, Marie-Hélène Mucchielli, 2008, Toxicology and applied pharmacology.

Identification of Modulators of the C. elegans Aryl Hydrocarbon Receptor and Characterization of Transcriptomic and Metabolic AhR-1 Profiles

X. Coumoul, S. Imbeaud, R. Barouki, 2022, Antioxidants.

Variants of the anti-Müllerian hormone gene in a compound heterozygote with the persistent Müllerian duct syndrome and his family

S. Imbeaud, M. New, J. Picard, 1992, Human Genetics.

The Gene for Anti-Müllerian Hormone

S. Imbeaud, J. Picard, R. Cate, 1994 .

Clinical aspects and molecular genetics of the persistent Müllerian duct syndrome

S. Imbeaud, R. Rey, J. Picard, 1997, Clinical endocrinology.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2017, Clinical Cancer Research.

Mir-31-3p as a predictive biomarker of cetuximab effects in a post hoc analysis of new EPOC phase III trial.

S. Imbeaud, P. Laurent-Puig, J. Bridgewater, 2014 .

Autosomal recessive segregation of a truncating mutation of anti-Müllerian type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro.

S. Imbeaud, I. Hughes, M. Dutertre, 2001, The Journal of clinical endocrinology and metabolism.

Surgical and genetic aspects of persistent müllerian duct syndrome.

S. Imbeaud, H. Reyes, I. Rosenthal, 1994, Journal of pediatric surgery.

Testicular degeneration in three patients with the persistent müllerian duct syndrome

S. Imbeaud, J. Wit, R. Lustig, 1995, European Journal of Pediatrics.

Nosology and Molecular Classification of Hepatocellular Adenomas

S. Imbeaud, J. Zucman‐Rossi, V. Paradis, 2016 .

A general framework for optimization of probes for gene expression microarray and its application to the fungus Podospora anserina

Olivier Lespinet, Philippe Silar, Véronique Berteaux-Lecellier, 2010, BMC Research Notes.

Genomic consequences of cytochrome P450 2C9 overexpression in human hepatoma cells.

P. Beaune, S. Imbeaud, I. de Waziers, 2009, Chemical research in toxicology.

Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition

F. Galateau-Sallé, S. Imbeaud, J. Zucman‐Rossi, 2014, Clinical Cancer Research.

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2017, Journal of hepatology.

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2019, Oncoimmunology.

A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

L. Zender, S. Imbeaud, J. Zucman‐Rossi, 2016, Nature Medicine.

Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.

S. Imbeaud, J. Zucman‐Rossi, P. Laurent-Puig, 2012, Journal of hepatology.

Patients and methods Patients and samples Between 1998 and 2009 , 244 patients underwent hepatic resection for colorectal liver metastasis at the Ambroise Paré Hospital

S. Imbeaud, J. Zucman‐Rossi, P. Laurent-Puig, 2012 .

The persistent Müllerian duct syndrome: A rare cause of cryptorchidism

S. Imbeaud, C. Adamsbaum, J. Zeller, 2005, European Journal of Pediatrics.

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

S. Imbeaud, D. Duffy, O. Schwartz, 2021, EBioMedicine.

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-B.1.1.7 or B.1.1.7 SARS-CoV-2 variants.

S. Imbeaud, D. Duffy, J. D. Di Santo, 2021, medRxiv.

XX sex reversal, palmoplantar keratoderma, and predisposition to squamous cell carcinoma: Genetic analysis in one family

S. Imbeaud, G. Camerino, L. Tiepolo, 2005, American journal of medical genetics. Part A.

Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab

S. Imbeaud, O. Schwartz, D. Planas, 2022, American Journal of Transplantation.

Anti-müllerian hormone: the Jost factor.

S. Imbeaud, R. Pepinsky, J. Picard, 1993 .

Functional Annotation: Extracting functional and regulatory order from microarrays

Charles Auffray, Sandrine Imbeaud, C. Auffray, 2005, Molecular systems biology.

Extracting functional and regulatory order from microarrays

Sandrine Imbeaud, Charles Auffray, C. Auffray, 2005 .

Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2016, Hepatology.

Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families.

S. Imbeaud, C. Belville, N. Josso, 1994, Human molecular genetics.

Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene.

S. Imbeaud, G. Camerino, P. Caron, 1999, The Journal of clinical endocrinology and metabolism.

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

S. Imbeaud, P. Laurent-Puig, H. Blons, 2017, Cancers.

SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution.

S. Imbeaud, T. Pupko, P. Gorwood, 2010, Human molecular genetics.

INCONSISTENCIES BETWEEN MAPS OF HUMAN CHROMOSOME 22 CORRELATE WITH INCREASED FREQUENCY OF DISEASE-RELATED LOCI

C. Auffray, D. Cox, S. Imbeaud, 2002 .

Netrin G1: its downregulation in the nucleus accumbens of cocaine‐conditioned mice and genetic association in human cocaine dependence

S. Imbeaud, P. Gorwood, N. Ramoz, 2018, Addiction biology.

Genome-Wide Gene Expression Profiling of Fertilization Competent Mycelium in Opposite Mating Types in the Heterothallic Fungus Podospora anserina

S. Imbeaud, H. Delacroix, R. Debuchy, 2011, PloS one.

From functional genomics to systems biology: concepts and practices.

Charles Auffray, Leroy Hood, Sandrine Imbeaud, 2003, Comptes rendus biologies.

DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2021, Hepatology.

Introduction to Palimpsest

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2019 .

Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer

Feng Liu, Jessica Zucman-Rossi, Sandrine Imbeaud, 2018, Bioinform..

Functional Study of the Hap4-Like Genes Suggests That the Key Regulators of Carbon Metabolism HAP4 and Oxidative Stress Response YAP1 in Yeast Diverged from a Common Ancestor

M. Bolotin-Fukuhara, S. Imbeaud, Marie-Hélène Mucchielli, 2014, PloS one.

Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia.

Charles Auffray, Kankan Wang, Hai Fang, 2005, Blood.

'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments.

Charles Auffray, Sandrine Imbeaud, C. Auffray, 2005, Drug discovery today.

Refined localization of twenty-one genes in subregion p13.1 of human chromosome 1

C. Auffray, S. Imbeaud, C. Chelala, 2001, Cytogenetic and Genome Research.

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis

S. Imbeaud, J. Zucman‐Rossi, V. Paradis, 2017, Nature Communications.

The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.

C. Auffray, S. Imbeaud, J. Zucman‐Rossi, 2008, Journal of Hepatology.

BAP1 mutations define a specific subgroup of hepatocellular carcinoma with fibrolamellar features and PKA activation Short title: BAP1 HCC have FLC features and activate PKA

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2020 .

BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2019, Journal of hepatology.

Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2013, International journal of cancer.

DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.

Paul Antoine Salin, S. Imbeaud, P. Gorwood, 2009, Human molecular genetics.

A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome.

S. Imbeaud, R. Rey, J. Picard, 1996, Human molecular genetics.

[Molecular biology of the persistent Müllerian duct syndrome].

S. Imbeaud, C. Belville, N. Josso, 1996, Contraception, fertilite, sexualite.

[Molecular biology of normal and pathologic anti-müllerian hormone].

S. Imbeaud, B. Knebelmann, J. Picard, 1991, Annales d'endocrinologie.

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.

Jessica Zucman-Rossi, Sandrine Imbeaud, Julien Calderaro, 2014, Cancer cell.

Mutations in the Saccharomyces cerevisiae Kinase Cbk1p Lead to a Fertility Defect That Can Be Suppressed by the Absence of Brr1p or Mpt5p (Puf5p), Proteins Involved in RNA Metabolism

C. Herbert, S. Imbeaud, Marie-Hélène Mucchielli, 2009, Genetics.

Predictive Biomarkers and Personalized Medicine Hsa-miR-31-3 p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

S. Imbeaud, S. Rossi, S. Knuutila, 2014 .

Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification

S. Imbeaud, J. Zucman‐Rossi, J. Dufour, 2013, Hepatology.

Insensitivity to anti–Müllerian hormone due to a mutation in the human anti–Müllerian hormone receptor

S. Imbeaud, M. Mattei, J. Bidart, 1995, Nature Genetics.

Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.

S. Imbeaud, O. Sterkers, M. Kalamarides, 2011, Neuro-oncology.

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

S. Imbeaud, S. Kernéis, O. Schwartz, 2021, Open forum infectious diseases.

A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

S. Imbeaud, J. Zucman‐Rossi, P. Laurent-Puig, 2013, Gastroenterology.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

V. de Lédinghen, S. Imbeaud, J. Zucman‐Rossi, 2018, Gastroenterology.

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2021, The Lancet. Oncology.

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

S. Imbeaud, J. Zucman‐Rossi, S. Rebouissou, 2009, Nature.

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma

S. Imbeaud, J. Zucman‐Rossi, V. Paradis, 2021, Gut.

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2019, Gastroenterology.

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

S. Imbeaud, J. Zucman‐Rossi, V. Paradis, 2017, Gastroenterology.

A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer

Charles Auffray, Sandrine Imbeaud, Marie-Anne Debily, 2009, PloS one.

Global Analysis of Extracytoplasmic Stress Signaling in Escherichia coli

S. Imbeaud, P. Bouloc, E. Jacquet, 2009, PLoS genetics.

Deciphering cellular states of innate tumor drug responses

Charles Auffray, Sandrine Imbeaud, Esther Graudens, 2006, Genome Biology.

Corrigendum: Signatures of mutational processes in human cancer

Roland Eils, Natalie Jäger, Adam P. Butler, 2013, Nature.

The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts

Teruyoshi Hishiki, Katsuhiko Murakami, Yoshihiro Kawahara, 2007, Nucleic Acids Res..

A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2019, Hepatology.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2018, International journal of cancer.

Germline and somatic DICER1 mutations in familial and sporadic liver tumors.

A. Luciani, S. Imbeaud, J. Zucman‐Rossi, 2017, Journal of hepatology.

Self–organized living systems: conjunction of a stable organization with chaotic fluctuations in biological space–time

Charles Auffray, Leroy Hood, Sandrine Imbeaud, 2003, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

M. Ziol, C. Copie-Bergman, S. Imbeaud, 2020, Hepatology.

HNF1α Inactivation Promotes Lipogenesis in Human Hepatocellular Adenoma Independently of SREBP-1 and Carbohydrate-response Element-binding Protein (ChREBP) Activation*

C. Auffray, S. Imbeaud, J. Zucman‐Rossi, 2007, Journal of Biological Chemistry.

The Human Anatomic Gene Expression Library (H-ANGEL), the H-Inv integrative display of human gene expression across disparate technologies and platforms

Teruyoshi Hishiki, Takuro Tamura, Charles Auffray, 2004, Nucleic Acids Res..

CLINICAL — LIVER A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection

S. Imbeaud, A. Reyniès, J. Llovet, 2013 .

Issues in Computational Methods for Functional Genomics and Systems Biology

Charles Auffray, Magali Roux-Rouquié, Sandrine Imbeaud, 2003, CMSB.

Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies

J. Casanova, S. Imbeaud, B. Autran, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Persistent müllerian duct syndrome (males with uterus): a pediatric problem].

S. Imbeaud, C. Adamsbaum, J. Zeller, 1994, Archives de pédiatrie.

Supplementary note : Palimpsest : an R package for studying mutational and structural variant signatures along clonal evolution in cancer

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2018 .

Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.

S. Imbeaud, T. Jouary, C. Collin, 2023, American Journal of Surgical Pathology.

Abstract 112: Genetic alterations in molecular tumor subgroups of malignant pleural mesothelioma

S. Imbeaud, J. Zucman‐Rossi, M. Jaurand, 2016 .

AAV2 and Hepatocellular Carcinoma.

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2016, Human gene therapy.

A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

L. Zender, S. Imbeaud, J. Zucman‐Rossi, 2016, Nature Medicine.

Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2013, International journal of cancer.

Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2016, Hepatology.

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

M. Esteller, V. Mazzaferro, S. Imbeaud, 2015, Hepatology.

A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2019, Hepatology.